BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fogari R, Zoppi A, Corradi L, Preti P, Malalamani GD, Mugellini A. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens. 2000;18:1871-1875. [PMID: 11132613 DOI: 10.1097/00004872-200018120-00023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Martell-Claros N, de la Cruz JJ. Manidipine for hypertension not controlled by dual therapy in patients with diabetes mellitus: a non-comparative, open-label study. Clin Drug Investig 2011;31:427-34. [PMID: 21528940 DOI: 10.2165/11587400-000000000-00000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Payeras AC, Sladek K, Lembo G, Alberici M. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study. Clin Drug Investig 2007;27:623-32. [PMID: 17705571 DOI: 10.2165/00044011-200727090-00004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Carthy ER. Autonomic dysfunction in essential hypertension: A systematic review. Ann Med Surg (Lond) 2014;3:2-7. [PMID: 25568776 DOI: 10.1016/j.amsu.2013.11.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
4 Richy FF, Laurent S. Efficacy and safety profiles of manidipine compared with amlodipine: a meta-analysis of head-to-head trials. Blood Press. 2010;20:54-59. [PMID: 20945994 DOI: 10.3109/08037051.2010.518670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cheer SM, McClellan K. Manidipine: a review of its use in hypertension. Drugs 2001;61:1777-99. [PMID: 11693466 DOI: 10.2165/00003495-200161120-00010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
6 Reboldi G, Gentile G, Angeli F, Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag 2009;5:411-27. [PMID: 19475778 DOI: 10.2147/vhrm.s4235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hassanabad MF, Fatehi M. Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis. Curr Diabetes Rev 2019;15:93-9. [PMID: 29692257 DOI: 10.2174/1573399814666180424123912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mugellini A, Vaccarella A, Celentano A, Scanferla F, Zoppi A, Fogari R. Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Blood Press Suppl 2005;1:6-13. [PMID: 16060411 DOI: 10.1080/08038020510040621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
9 McKeage K, Scott LJ. Manidipine: a review of its use in the management of hypertension. Drugs. 2004;64:1923-1940. [PMID: 15329044 DOI: 10.2165/00003495-200464170-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
10 Coats AJ, Cruickshank JM. Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications. International Journal of Cardiology 2014;174:702-9. [DOI: 10.1016/j.ijcard.2014.04.204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kyselovic J, Krenek P, Wibo M, Godfraind T. Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats. Br J Pharmacol 2001;134:1516-22. [PMID: 11724758 DOI: 10.1038/sj.bjp.0704398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
12 Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension. Hypertension 2007;49:1047-55. [PMID: 17353513 DOI: 10.1161/HYPERTENSIONAHA.106.084301] [Cited by in Crossref: 116] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
13 Toal CB, Meredith PA, Elliott HL. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS. Blood Press 2012;21 Suppl 1:3-10. [PMID: 22762301 DOI: 10.3109/08037051.2012.690615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
14 Bellinghieri G, Mazzaglia G, Savica V, Santoro D. Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial. Ren Fail 2003;25:681-9. [PMID: 14575277 DOI: 10.1081/jdi-120024284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
15 Ram CV. Hypertension, possible vascular protection and lercanidipine. Expert Rev Cardiovasc Ther 2006;4:783-8. [PMID: 17173495 DOI: 10.1586/14779072.4.6.783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Wenzel RR. Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs 2005;65 Suppl 2:29-39. [PMID: 16398060 DOI: 10.2165/00003495-200565002-00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mccormack PL, Keating GM. Delapril/Manidipine: . Drugs 2006;66:961-9. [DOI: 10.2165/00003495-200666070-00014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Skurk T, Lee YM, Nicuta-Rölfs TO, Haastert B, Wirth A, Hauner H. Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension. Diabetes Obes Metab 2004;6:56-62. [PMID: 14686964 DOI: 10.1111/j.1463-1326.2004.00316.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
19 Cruickshank JM. The Role of Beta-Blockers in the Treatment of Hypertension. Adv Exp Med Biol 2017;956:149-66. [PMID: 27957711 DOI: 10.1007/5584_2016_36] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Yeung PK, Xu Z, Seeto D. Diltiazem reduces mortality and breakdown of ATP in red blood cell induced by isoproterenol in a freely moving rat model in vivo. Metabolites 2014;4:775-89. [PMID: 25215514 DOI: 10.3390/metabo4030775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Žaliūnas R, Braždžionytė J, Zabiela V, Jurkevičius R. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction. International Journal of Cardiology 2005;101:347-53. [DOI: 10.1016/j.ijcard.2004.03.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Meredith PA, Elliott HL. Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences. J Hypertens 2004;22:1641-8. [PMID: 15311086 DOI: 10.1097/00004872-200409000-00002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
23 Fogari R, Mugellini A, Circelli M, Cremonesi G. Combination delapril/manidipine as antihypertensive therapy in high-risk patients. Clin Drug Investig 2011;31:439-53. [PMID: 21627336 DOI: 10.2165/11589000-000000000-00000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Coca A. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage. Expert Review of Cardiovascular Therapy 2014;5:147-59. [DOI: 10.1586/14779072.5.2.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World J Cardiol 2014;6:517-30. [PMID: 25068013 DOI: 10.4330/wjc.v6.i7.517] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
26 Levine CB, Fahrbach KR, Frame D, Connelly JE, Estok RP, Stone LR, Ludensky V. Effect of amlodipine on systolic blood pressure. Clinical Therapeutics 2003;25:35-57. [DOI: 10.1016/s0149-2918(03)90007-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
27 Rizos CV. Manidipine: A different dihydropyridine. WJH 2011;1:3. [DOI: 10.5494/wjh.v1.i1.3] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
28 Colle SD, Morello F, Rabbia F, Milan A, Naso D, Puglisi E, Mulatero P, Veglio F. Antihypertensive Drugs and the Sympathetic Nervous System. Journal of Cardiovascular Pharmacology 2007;50:487-96. [DOI: 10.1097/fjc.0b013e318135446c] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
29 Mccormack PL, Wagstaff AJ. Lacidipine: A Review of its Use in the Management of Hypertension. Drugs 2003;63:2327-56. [DOI: 10.2165/00003495-200363210-00008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
30 Aksnes TA, Flaa A, Sevre K, Mundal HH, Rostrup M, Kjeldsen SE. Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT‐1 receptor blockade. Blood Pressure 2009;17:156-63. [DOI: 10.1080/08037050802162847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Coca A, Mazón P, Aranda P, Redón J, Divisón JA, Martínez J, Calvo C, Galcerán JM, Barrios V, Coll ARI. Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Review of Cardiovascular Therapy 2014;11:91-105. [DOI: 10.1586/erc.12.155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
32 Malacco E, Piazza S, Scandiani L, Zoppi A. Effects of valsartan/ hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients. Adv Therapy 2004;21:149-61. [DOI: 10.1007/bf02850120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
33 González A, López B, Ravassa S, Querejeta R, Larman M, Díez J, Fortuño MA. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension. 2002;39:75-80. [PMID: 11799082 DOI: 10.1161/hy0102.100788] [Cited by in Crossref: 76] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
34 Roca-Cusachs A, Triposkiadis F. Antihypertensive effect of manidipine. Drugs 2005;65 Suppl 2:11-9. [PMID: 16398058 DOI: 10.2165/00003495-200565002-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
35 Fogari R. Ankle oedema and sympathetic activation. Drugs. 2005;65 Suppl 2:21-27. [PMID: 16398059 DOI: 10.2165/00003495-200565002-00004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]